Production and characterization of a monoclonal antibody against Niemann Pick type C protein

Ihid C. Leao, Milton Maciel, James Hildreth

Research output: Contribution to journalArticle

Abstract

Niemann Pick type C is a severe, incurable disease caused, in the majority of cases, by mutations in the Niemann Pick type C protein 1 (NPC1). The pathology and biochemical changes associated with the disease have been extensively studied. However, the function of the protein is still unknown, and recent studies challenge the established concept that a defect in cholesterol and sphingolipids transport is the primary cause of this human lipidosis. Clearly defining the mechanisms by which defects in this protein lead to the disease phenotype will require further studies on the structure and function of this protein. Therefore, the development of a well-characterized monoclonal antibody (MAb) against this protein to facilitate such studies is an important goal. Here, we describe the production and characterization of such a MAb. The antibody is demonstrated to be highly specific and species cross-reactive. Function studies show that the antibody induces the NPC1 disease phenotype in cells, making it highly likely that the antibody blocks function of the NPC1 protein.

Original languageEnglish (US)
Pages (from-to)216-224
Number of pages9
JournalHybridoma
Volume25
Issue number4
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Protein C
Monoclonal Antibodies
Proteins
Antibodies
Lipidoses
Phenotype
Sphingolipids
Cholesterol
Pathology
Mutation

ASJC Scopus subject areas

  • Immunology
  • Genetics

Cite this

Production and characterization of a monoclonal antibody against Niemann Pick type C protein. / Leao, Ihid C.; Maciel, Milton; Hildreth, James.

In: Hybridoma, Vol. 25, No. 4, 11.2006, p. 216-224.

Research output: Contribution to journalArticle

@article{6fdc2f8244d1461dafddb75349099b60,
title = "Production and characterization of a monoclonal antibody against Niemann Pick type C protein",
abstract = "Niemann Pick type C is a severe, incurable disease caused, in the majority of cases, by mutations in the Niemann Pick type C protein 1 (NPC1). The pathology and biochemical changes associated with the disease have been extensively studied. However, the function of the protein is still unknown, and recent studies challenge the established concept that a defect in cholesterol and sphingolipids transport is the primary cause of this human lipidosis. Clearly defining the mechanisms by which defects in this protein lead to the disease phenotype will require further studies on the structure and function of this protein. Therefore, the development of a well-characterized monoclonal antibody (MAb) against this protein to facilitate such studies is an important goal. Here, we describe the production and characterization of such a MAb. The antibody is demonstrated to be highly specific and species cross-reactive. Function studies show that the antibody induces the NPC1 disease phenotype in cells, making it highly likely that the antibody blocks function of the NPC1 protein.",
author = "Leao, {Ihid C.} and Milton Maciel and James Hildreth",
year = "2006",
month = "11",
language = "English (US)",
volume = "25",
pages = "216--224",
journal = "Monoclonal Antibodies in Immunodiagnosis and Immunotherapy",
issn = "2167-9436",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Production and characterization of a monoclonal antibody against Niemann Pick type C protein

AU - Leao, Ihid C.

AU - Maciel, Milton

AU - Hildreth, James

PY - 2006/11

Y1 - 2006/11

N2 - Niemann Pick type C is a severe, incurable disease caused, in the majority of cases, by mutations in the Niemann Pick type C protein 1 (NPC1). The pathology and biochemical changes associated with the disease have been extensively studied. However, the function of the protein is still unknown, and recent studies challenge the established concept that a defect in cholesterol and sphingolipids transport is the primary cause of this human lipidosis. Clearly defining the mechanisms by which defects in this protein lead to the disease phenotype will require further studies on the structure and function of this protein. Therefore, the development of a well-characterized monoclonal antibody (MAb) against this protein to facilitate such studies is an important goal. Here, we describe the production and characterization of such a MAb. The antibody is demonstrated to be highly specific and species cross-reactive. Function studies show that the antibody induces the NPC1 disease phenotype in cells, making it highly likely that the antibody blocks function of the NPC1 protein.

AB - Niemann Pick type C is a severe, incurable disease caused, in the majority of cases, by mutations in the Niemann Pick type C protein 1 (NPC1). The pathology and biochemical changes associated with the disease have been extensively studied. However, the function of the protein is still unknown, and recent studies challenge the established concept that a defect in cholesterol and sphingolipids transport is the primary cause of this human lipidosis. Clearly defining the mechanisms by which defects in this protein lead to the disease phenotype will require further studies on the structure and function of this protein. Therefore, the development of a well-characterized monoclonal antibody (MAb) against this protein to facilitate such studies is an important goal. Here, we describe the production and characterization of such a MAb. The antibody is demonstrated to be highly specific and species cross-reactive. Function studies show that the antibody induces the NPC1 disease phenotype in cells, making it highly likely that the antibody blocks function of the NPC1 protein.

UR - http://www.scopus.com/inward/record.url?scp=33750976952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750976952&partnerID=8YFLogxK

M3 - Article

C2 - 16934018

AN - SCOPUS:33750976952

VL - 25

SP - 216

EP - 224

JO - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

JF - Monoclonal Antibodies in Immunodiagnosis and Immunotherapy

SN - 2167-9436

IS - 4

ER -